2002
DOI: 10.1002/hed.10103
|View full text |Cite
|
Sign up to set email alerts
|

Somatostatin analog treatment of a cervical thoracic duct fistula

Abstract: The use of somatostatin analog can increase the success of conservative management of thoracic duct fistulae.

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
4
1

Citation Types

1
32
1
1

Year Published

2006
2006
2022
2022

Publication Types

Select...
6
3

Relationship

0
9

Authors

Journals

citations
Cited by 57 publications
(38 citation statements)
references
References 16 publications
1
32
1
1
Order By: Relevance
“…However, in the present series. A systemic approach to decrease lymphatic output is the application of somatostatin analoga that has not been described in larger number of patients [27].…”
Section: Discussionmentioning
confidence: 99%
“…However, in the present series. A systemic approach to decrease lymphatic output is the application of somatostatin analoga that has not been described in larger number of patients [27].…”
Section: Discussionmentioning
confidence: 99%
“…Conservative approaches to decreasing chyle production involve the placement of intercostal tube drainage for thoracentesis and absolute oral intake diet with total parenteral nutrition or an enteral diet rich in low-fat, medium-chain triglycerides [1,3,4]. Also, the use of somatostatin or octreotide has been used to decrease intestinal chyle production [5,6]. Unfortunately, conservative management is of low effi cacy in neoplasic chylothorax.…”
Section: Discussionmentioning
confidence: 99%
“…[4][5][6][7] Nutritional treatment leads to closure of the fistula in up to 80% of patients. 8 Many physicians consider first-line therapy to be bowel rest, parenteral nutrition, and chyle drainage.…”
Section: Discussionmentioning
confidence: 99%